Research map: Operationalizing Single-Dose Long-Acting Lipoglycopeptides for Treatment of ABSSSI in a U.S. Community Hospital Emergency Department

Back to the article

Papers in this map

  1. Executive Summary: Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America · Dennis Leroy Stevens · 2014 · 1542 citations · Cited by this paper
  2. Effectiveness and Tolerability of Vortioxetine in Major Depressive Disorder: A Real-World Study in Switzerland · 2026 · Related
  3. Once-Weekly Dalbavancin versus Daily Conventional Therapy for Skin Infection · Helen W. Boucher · 2014 · 436 citations · Cited by this paper
  4. Clinical Benefit of Multiple Myeloma Drugs at Regulatory Approval in Brazil, Europe, and the USA: A Retrospective Cohort Study (2003–2024) · 2026 · Related
  5. Single-Dose Oritavancin in the Treatment of Acute Bacterial Skin Infections · G. Ralph Corey · 2014 · 310 citations · Cited by this paper
  6. Desvenlafaxine as a Potential First-Line Treatment for Major Depressive Disorder: A Comprehensive Review and Consensus-Based Clinical Perspective on Efficacy, Safety and Patient Selection Profiles · 2026 · Related
  7. Factors Associated with the Decision to Hospitalize Emergency Department Patients with a Skin and Soft Tissue Infection · David A. Talan · 2015 · 81 citations · Cited by this paper
  8. Determinants and Prognostic Impact of In-Hospital Sodium-Glucose Cotransporter-2 Inhibitor Initiation in Patients with Heart Failure · 2026 · Related
  9. Identifying patients with cellulitis who are likely to require inpatient admission after a stay in an ED observation unit · Kathryn A. Volz · 2012 · 46 citations · Cited by this paper
  10. Missed Opportunities in the Therapeutic Patterns of Chronic Obstructive Pulmonary Disease: A Real-World Italian Study on the Impact of Severe Exacerbation on Mortality and Hospital Re-admission · 2026 · Related
  11. Guidelines vs Actual Management of Skin and Soft Tissue Infections in the Emergency Department · Rahul S. Kamath · 2018 · 45 citations · Cited by this paper
  12. Milsaperidone: First Approval · 2026 · Related
  13. Review: A Safety Profile of Dalbavancin for On- and Off-Label Utilization · Oriana Simonetti · 2021 · 44 citations · Cited by this paper
  14. Cost-Consequences Analysis of Biologic Treatments for Moderate-to-Severe Crohn’s Disease Using Real-World Transition Probability and Cost Data in Thailand · 2026 · Related
  15. Current practices and challenges of outpatient parenteral antimicrobial therapy: a narrative review · Zenaw T Wolie · 2024 · 41 citations · Cited by this paper
  16. Amyloid-Related Imaging Abnormalities in Anti-amyloid Therapy: Clinical Implications of Kinetics for Safer Use and Risk Stratification · 2026 · Related
  17. Single-dose dalbavancin and patient satisfaction in an outpatient setting in the treatment of acute bacterial skin and skin structure infections · Urania Rappo · 2019 · 40 citations · Cited by this paper
  18. Over-the-Counter Product Use Among Individuals with Vitiligo: A Cross-Sectional International Survey · 2026 · Related
  19. Economic burden of hospital admissions for patients with acute bacterial skin and skin structure infections in the United States · Katelyn R. Keyloun · 2018 · 23 citations · Cited by this paper
  20. Evaluating the Use of Dalbavancin for Off-Label Indications · Katherine Taylor · 2022 · 23 citations · Cited by this paper
  21. Pathway with single‐dose long‐acting intravenous antibiotic reduces emergency department hospitalizations of patients with skin infections · David A. Talan · 2021 · 19 citations · Cited by this paper
  22. Dalbavancin Use in the Emergency Department Setting · Mitulkumar Patel · 2019 · 18 citations · Cited by this paper
  23. Early Directed Oritavancin Therapy in the Emergency Department May Lead to Hospital Avoidance Compared to Standard Treatment for Acute Bacterial Skin and Skin Structure Infections: A Real-World Retrospective Analysis · Brittany Helton · 2020 · 13 citations · Cited by this paper
  24. Stewarding the Costly Antibiotic: Considerations for Dalbavancin · Paul Brandon Bookstaver · 2020 · 7 citations · Cited by this paper
  25. Single Intravenous Dose Dalbavancin Pathway for the Treatment of Acute Bacterial Skin and Skin Structure Infections: Considerations for Emergency Department Implementation and Cost Savings · Frank LoVecchio · 2024 · 6 citations · Cited by this paper
  26. Transition of Care with Dalbavancin: a Successful Cost-Saving Stewardship Program through Decreased Length of Stay · Colleen M. Terriff · 2017 · 4 citations · Cited by this paper
  27. Finding the niche: An interprofessional approach to defining oritavancin use criteria in the emergency department · Jared Baxa · 2019 · 4 citations · Cited by this paper
  28. Budget Impact and Financial Analysis of Outpatient Dalbavancin in an Urban, Non-Teaching, Community Hospital · Karan Raja · 2025 · 3 citations · Cited by this paper
  29. Pharmacist-Directed Use of Dalbavancin in Acute Bacterial Skin and Skin Structure Infections to Reduce Hospital Length of Stay · Bruce M Jones · 2017 · 2 citations · Cited by this paper
  30. 600: IMPLEMENTATION AND EVALUATION OF A DALBAVANCIN PROTOCOL FOR MODERATE SSSIS IN THE ED · Amanda Holyk · 2019 · 2 citations · Cited by this paper
  31. Impact of first-line dalbavancin for cellulitis on hospital admissions and costs: A case series · Kailey Ben-Sassi · 2024 · 2 citations · Cited by this paper
  32. Use of dalbavancin in treatment of acute bacterial skin and skin structure infections: Case series from a Canadian perspective · Wayne Leung · 2025 · 2 citations · Cited by this paper
  33. P-744. Admission Avoidance: A Protocol for Using Dalbavancin in the Emergency Department for Acute Bacterial Skin and Skin Structure Infections · Katherine N. Weller · 2025 · 1 citation · Cited by this paper
  34. Evaluating Risk Factors for Short Versus Long Hospital Stay for Cellulitis to Guide the Development of a Long-acting Lipoglycopeptide Use Decision Algorithm · Cole Orlikowski · 2025 · 1 citation · Cited by this paper
  35. P-757. Does Dalbavancin Utilization in the ED Reduce Hospital Admission? · Nadim Sidik · 2026 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)